iRobot (NASDAQ:IRBT): Needham raised its price target for iRobot to $39 from $32 following the company’s second-quarter results and has reiterated a Buy rating on the stock. The firm says the post-earnings pullback in shares was not surprising given the recent rally, and that iRobot’s fundamentals remains solid.
Baidu (NASDAQ:BIDU): CLSA has upgraded Baidu to Buy from Underperform, citing Baidu’s strong revenue growth in the second quarter and adding that the quarter will likely mark a bottom driven by mobile monetization. The price target is now up to $150 per share.
Thermo Fisher (NYSE:TMO): RW Baird raised its price target on Thermo Fisher following solid second-quarter results. The firm cited accretion from its Life transaction, positive management tone, and improvement in end markets. Shares are currently Outperform rated and have been raised to a target of $105 from $100.
Sarepta (NASDAQ:SRPT): RW Baird’s short- and long-term investment thesis on Sarepta was increased following its corporate update. The firm cited its decision to announce the NDA filing as an indication the Food and Drug Administration is more positively inclined toward its drug eteplirsen than previously thought. Baird also added that the company’s manufacturing scale-up appears to be ahead of projections. Sarepta shares are currently Outperform rated with a price target of $63.